/1310_2 1 ALTERITY THERAPEUTICS LIMITED ACN 080 699 065 (Company) CORPORATE GOVERNANCE STATEMENT This Corporate Governance Statement is current as at 28 August 2026 and has been approved by the Board of the Company on that date. This Corporate Governance Statement...
Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Appendix 4G
- Application for quotation of securities - ATH
- Disclosure Under Takeovers Panel GN 20
- Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
- Granted New U.S. Composition of Matter Patent for ATH434
Later from Alterity Therapeutics
- Appendix 4E and 2026 Annual Report
- $4.2M Options Underwriting Agreement Executed
- Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC
- Change of Director's Interest Notice - Marks
- Change of Director's Interest Notice - Stamler
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics